Latest Ratings for ABBV Date Firm Action From To Feb 2022 UBS Downgrades Buy Neutral Feb 2022 Mizuho Maintains Buy Feb 2022 Barclays Maintains Equal-Weight View More Analyst Ratings for ABBV View the Latest Analyst Ratings read more
Piper Sandler analyst maintains an Overweight rating on Teva, citing positive feedback on duvakitug’s potential in treating IBD. Latest Ratings for TEVA Date Firm Action From To Feb 2022 Barclays Maintains Equal-Weight Jan 2022 Argus Research Downgrades Buy Hold Oct 2021 Raymond James Downgrades Outperform Market Perform View More Analyst Ratings for TEVA View the…
Truist Securities analyst initiates coverage on chemicals stocks before earnings release. Companies include Chemours, Tronox, Minerals Tech, and Westlake. Latest Ratings for CC Date Firm Action From To Feb 2022 RBC Capital Maintains Outperform Feb 2022 JP Morgan Maintains Neutral Jan 2022 UBS Maintains Neutral View More Analyst Ratings for CC View the Latest Analyst…
Analyst revises ratings/price forecast on clean energy stocks ahead of earnings release. Highlights key areas to watch for each company. read more
The price of Move (CRYPTO: MOVE), the native token for the Movement Network, has rocketed upwards following a multi-million dollar investment from World Liberty Financial, a firm with read more